We’re getting closer to that Star Trek medical Tricorder concept.
First prize in the Qualcomm Tricorder XPrize was awarded to Final Frontier Medical Devices, a team in Pennsylvania. The team, led by brothers Dr. Basil Harris, an emergency medicine physician, and George Harris, a network engineer, created an artificial intelligence engine called DxtER that learns to diagnose medical conditions via data from emergency medicine and analyzing patients.
Final Frontier Medical Devices was awarded $2.6 million at the Qualcomm Tricorder XPrize ceremony on Wednesday.
DxtER operates at the intersection of a few key trends such as artificial intelligence and the Internet of things. The concept of a medical Tricorder is also becoming more possible as use cases for the Internet of things–health, transportation, smart home, smart city and other areas–blend together.
More on health, IoT and AI: From heart attacks to fainting, this watch flags up health threats before they strike | IBM’s Watson does healthcare: Data as the foundation for cognitive systems for population health | Google’s DeepMind and the NHS: A glimpse of what AI means for the future of healthcare | AI that knows you’re sick before you do: IBM’s five-year plan to remake healthcare | Rebuilding the brain: Using AI, electrodes, and machine learning to bridge gaps in the human nervous system
Harris said that a device such as DxtER could address 90 percent of the cases in the emergency room without leaving the home. After all, people are really going for a diagnosis.
Here’s the quick overview of DxtER, which was basically cooked up in Harris’ den and house with his team in Paoli, PA:
- The system includes a series of non-invasive sensors to collect vital signs, body chemistry and biological functions.
- From there, data is used by the device’s diagnostic engine to make an assessment.
- The device is designed to monitor health and diagnose illnesses in a home setting.
- DxtER is autonomous, but can share information with healthcare providers if given permission.
Second prize in the challenge, good for $1 million, was given to Dynamical Biomarkers Group, a Taiwan-based outfit led by Medical School Associate Professor Chung-Kang Peng, Ph.D.
Dynamical Biomarkers Group paired algorithms and analytics in a device controlled by a smartphone. HTC Research helped with the prototype.
There were more than 300 teams vying for the Qualcomm-funded XPrize. The challenge revolved around creating a simple user experience that could diagnose 13 disease stats with their prototypes.